|
|
|
Congressional
Testimony
|
|
|
|
|
|
|
|
|
|
- December 13, 2005
Robert J. Meyer, M.D.
Director of the Office of New Drug Evaluation II
Subject: Hearing on FDA’s Role in Regard to Controlled Substances
Before: Subcommittee on Oversight and Investigations
- November 1, 2005
Randall W. Lutter, Ph.D.
Acting Associate Commissioner for Policy and Planning
Subject: Hearing on Counterfeit Drugs within the United
States
Before: Subcommittee on Criminal Justice
- September 29, 2005
Rachel E. Behrman, M.D., M.P.H.
Deputy Director, Office of Medical Policy
Subject: The Impact of Direct-to-Consumer Drug Advertising on Seniors' Health and Health Care Costs
Before: Special Committee on Aging
- September 13, 2005
Robert J. Meyer, M.D.
Director, Office of Drug Evaluation II
Subject: Prescription
Drug Abuse
Before: Committee on Government Reform
- September 7, 2005
Richard Pazdur, M.D.
Director, Office of Oncology Drug Products
Subject: Women and Gynecologic Cancers
Before: Committee on Government Reform
- July 20, 2005
Robert E. Brackett, Ph.D.
Director Center for Food Safety and Applied Nutrition
Subject: Counterterrorism Activities
Before: Committee for Agriculture, Nutrition and Forestry, United
States Senate
- June 14, 2005
Robert E. Brackett, Ph.D.
Director Center for Food Safety and Applied Nutrition
Subject: Bioengineered Foods
Before: Committee for Agriculture, Nutrition and Forestry, United States Senate
- May 17 , 2005
Robert E. Brackett, Ph.D.
Director Center for Food Safety and Applied Nutrition
Subject: Food Supply
Before: Before the Committee on Goverment Reform
- May 5 , 2005
Steven Galson, M.D., M.P.H.
Acting Director, Center for Drug Evaluation and Research
Subject: Drug Safety
Before: Before the Committee on Goverment Reform
- May 4 , 2005
Jesse L. Goodman, M.D., M.P.H.
Director, Center for Biologics, Evaluation and Research
Subject: Influenza Vaccine Supply
Before: Before the Committee on Energy and Commerce
- March 17 , 2005
Lester M. Crawford, D.V.M., Ph.D.
Acting Commissioner of Food and Drugs
Subject: Confirmation Statement
Before: Committee on Health, Education, Labor and Pensions
- March 1 & 3, 2005
Sandra L. Kweder, M.D. and Janet Woodcock, M.D.
Subject: Drug Safety
Before: Committee on Health, Education, Labor and Pensions
- February 10, 2005
Jesse L. Goodman, M.D., M.P.H.
Director, Center for Biologics Evaluation and Research
Subject: Influenza Vaccine: Current Status, Lessons Learned and Preparing for the Future
Before: Committee on Government Reform,
United States House of Representatives
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|